Bicara Therapeutics Inc. (BCAX)
NASDAQ: BCAX · Real-Time Price · USD
25.86
+0.94 (3.77%)
At close: Aug 19, 2026, 4:00 PM EDT
25.86
0.00 (0.00%)
After-hours: Aug 19, 2026, 7:30 PM EDT
Bicara Therapeutics Market Cap
Bicara Therapeutics has a market cap or net worth of $1.71 billion as of August 19, 2026. Its market cap has increased by 173.43% in one year.
Market Cap
1.71B
Enterprise Value
1.22B
1-Year Change
173.43%
Ranking
Category
Stock Price
$25.86
ChartMarket Cap Chart
Since the IPO on September 13, 2024, Bicara Therapeutics's market cap has increased from $931.70M to $1.71B, an increase of 83.67%. That is a compound annual growth rate of 36.99%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 19, 2026 | 1.71B | 85.60% |
| Dec 31, 2025 | 921.98M | -2.74% |
| Dec 31, 2024 | 947.92M | 1.74% |
| Sep 13, 2024 | 931.70M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AnaptysBio | 1.75B |
| Avalyn Pharma | 1.72B |
| Braveheart Bio | 1.72B |
| Fortrea Holdings | 1.67B |
| Recursion Pharmaceuticals | 1.66B |
| Ascentage Pharma Group International | 1.63B |
| Intellia Therapeutics | 1.63B |
| Maze Therapeutics | 1.62B |